Virtus ETF Advisers LLC Gh Research PLC Transaction History

Virtus ETF Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$10.15 - $16.15 $751 - $1,195	74 Added 0.74%	10,026 $117,000
Q2 2022 Aug 12, 2022	BUY	$8.99 - $19.87 $29,352 - $64,875	3,265 Added 48.83%	9,952 $99,000
Q1 2022 May 16, 2022	SELL	$15.48 - $23.98 $6,176 - $9,568	-399 Reduced 5.63%	6,687 $122,000
Q4 2021 Feb 14, 2022	BUY	$14.1 - $27.9 $99,912 - $197,699	7,086 New	7,086 $165,000

23.5M

63.1K

1.9K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $433M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.